|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-1-31
|
|
pubmed:abstractText |
Clinical drawbacks of beta-blocker treatment in stable angina have motivated researchers to provide alternative heart rat lowering agents, such as tedisamil which additionally exerts anti-ischemic and antiarrhythmic effects by blockade of cellular repolarizing K(+) currents.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0300-5860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
838-49
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10552188-Adrenergic beta-Antagonists,
pubmed-meshheading:10552188-Angina Pectoris,
pubmed-meshheading:10552188-Anti-Arrhythmia Agents,
pubmed-meshheading:10552188-Atenolol,
pubmed-meshheading:10552188-Bicyclo Compounds, Heterocyclic,
pubmed-meshheading:10552188-Coronary Circulation,
pubmed-meshheading:10552188-Cyclopropanes,
pubmed-meshheading:10552188-Double-Blind Method,
pubmed-meshheading:10552188-Exercise Test,
pubmed-meshheading:10552188-Female,
pubmed-meshheading:10552188-Heart Rate,
pubmed-meshheading:10552188-Hemodynamics,
pubmed-meshheading:10552188-Humans,
pubmed-meshheading:10552188-Male,
pubmed-meshheading:10552188-Norepinephrine,
pubmed-meshheading:10552188-Potassium Channel Blockers,
pubmed-meshheading:10552188-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
[Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol].
|
|
pubmed:affiliation |
Kerckhoff-Klinik GmbH, Benekestr. 2-8, D-61231 Bad Nauheim. Veselin.Mitrovic@kerckhoff.med.uni-giessen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Randomized Controlled Trial
|
